Evidence map›Paper›PMID 29915061›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

A versatile nanobody-based toolkit to analyze retrograde transport from the cell surface.

Dominik P Buser, Kai D Schleicher, Cristina Prescianotto-Baschong, Martin Spiess

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Proximity-activated DNA scanning encoded sequencing for massive access to membrane proteins nanoscale organization.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Protein sorting from endosomes to the TGN.Frontiers in cell and developmental biology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Exploring cellular biochemistry with nanobodies.The Journal of biological chemistry · 2020
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dominik P BuserBiozentrum, University of Basel, CH-4056 Basel, Switzerland dominik-pascal.buser@unibas.ch martin.spiess@unibas.ch.
Kai D SchleicherBiozentrum, University of Basel, CH-4056 Basel, Switzerland.
Cristina Prescianotto-BaschongBiozentrum, University of Basel, CH-4056 Basel, Switzerland.
Martin SpiessBiozentrum, University of Basel, CH-4056 Basel, Switzerland dominik-pascal.buser@unibas.ch martin.spiess@unibas.ch.
University of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retrograde transport of membranes and proteins from the cell surface to the Golgi and beyond is essential to maintain homeostasis, compartment identity, and physiological functions. To study retrograde traffic biochemically, by live-cell imaging or by electron microscopy, we engineered functionalized anti-GFP nanobodies (camelid VHH antibody domains) to be bacterially expressed and purified. Tyrosine sulfation consensus sequences were fused to the nanobody for biochemical detection of

Indexed as

Adaptor Protein Complex 1AnimalsBiological Transport, ActiveCamelusCell MembraneDNA-(Apurinic or Apyrimidinic Site) LyaseEndonucleasesEndosomesGreen Fluorescent ProteinsHeLa CellsHumansMicroscopy, ElectronMicroscopy, FluorescenceMultifunctional EnzymesReceptor, IGF Type 2Single-Domain AntibodiesAdaptor Protein Complex 1APEX2 protein, humancation-dependent mannose-6-phosphate receptorDNA-(Apurinic or Apyrimidinic Site) LyaseEndonucleasesGreen Fluorescent ProteinsMultifunctional EnzymesReceptor, IGF Type 2Single-Domain AntibodiesAP-1mannose-6-phosphate receptorsnanobodiesretrograde transporttyrosine sulfation

Identifiers

PMID29915061
PMCPMC6142194
OpenAlexW2808739502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.